These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 12163621)

  • 1. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
    Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J
    J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term Donepezil therapy on rCBF of Alzheimer's patients.
    Nobili F; Vitali P; Canfora M; Girtler N; De Leo C; Mariani G; Pupi A; Rodriguez G
    Clin Neurophysiol; 2002 Aug; 113(8):1241-8. PubMed ID: 12140003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPECT follow-up study of cerebral blood flow changes during Donepezil therapy in patients with Alzheimer's disease.
    Shimizu S; Hanyu H; Iwamoto T; Koizumi K; Abe K
    J Neuroimaging; 2006 Jan; 16(1):16-23. PubMed ID: 16483272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative EEG and perfusional single photon emission computed tomography correlation during long-term donepezil therapy in Alzheimer's disease.
    Rodriguez G; Vitali P; Canfora M; Calvini P; Girtler N; De Leo C; Piccardo A; Nobili F
    Clin Neurophysiol; 2004 Jan; 115(1):39-49. PubMed ID: 14706467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rivastigmine on regional cerebral blood flow in Alzheimer's disease.
    Cerci SS; Tamam Y; Kaya H; Yildiz M; Arslan S
    Adv Ther; 2007; 24(3):611-21. PubMed ID: 17660172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease.
    Ceravolo R; Volterrani D; Tognoni G; Dell'Agnello G; Manca G; Kiferle L; Rossi C; Logi C; Strauss HW; Mariani G; Murri L
    Clin Neuropharmacol; 2004; 27(4):166-70. PubMed ID: 15319702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness.
    Wolfson C; Oremus M; Shukla V; Momoli F; Demers L; Perrault A; Moride Y
    Clin Ther; 2002 Jun; 24(6):862-86; discussion 837. PubMed ID: 12117079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study.
    Santoro A; Siviero P; Minicuci N; Bellavista E; Mishto M; Olivieri F; Marchegiani F; Chiamenti AM; Benussi L; Ghidoni R; Nacmias B; Bagnoli S; Ginestroni A; Scarpino O; Feraco E; Gianni W; Cruciani G; Paganelli R; Di Iorio A; Scognamiglio M; Grimaldi LM; Gabelli C; Sorbi S; Binetti G; Crepaldi G; Franceschi C
    CNS Drugs; 2010 Feb; 24(2):163-76. PubMed ID: 20088621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the regional cerebral blood flow changes during long-term donepezil therapy in patients with Alzheimer's disease using 3DSRT.
    Kimura N; Kumamoto T; Masuda T; Hanaoka T; Okazaki T; Arakawa R
    J Neuroimaging; 2012 Jul; 22(3):299-304. PubMed ID: 21699607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
    Kaasinen V; Någren K; Järvenpää T; Roivainen A; Yu M; Oikonen V; Kurki T; Rinne JO
    J Clin Psychopharmacol; 2002 Dec; 22(6):615-20. PubMed ID: 12454562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: a longitudinal SPECT study.
    Hanyu H; Sato T; Hirao K; Kanetaka H; Iwamoto T; Koizumi K
    J Neurol Sci; 2010 Mar; 290(1-2):96-101. PubMed ID: 19931870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of therapeutic response to donepezil by positron emission tomography.
    Shimada A; Hashimoto H; Kawabe J; Higashiyama S; Kai T; Kataoka K; Tagawa R; Kawarada Y; Nakanishi A; Inoue K; Shiomi S; Kiriike N
    Osaka City Med J; 2011 Jun; 57(1):11-9. PubMed ID: 22106763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc-HMPAO regional cerebral blood flow and quantitative electroencephalography in Alzheimer's disease: a correlative study.
    Rodriguez G; Nobili F; Copello F; Vitali P; Gianelli MV; Taddei G; Catsafados E; Mariani G
    J Nucl Med; 1999 Apr; 40(4):522-9. PubMed ID: 10210209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease.
    Nakano S; Asada T; Matsuda H; Uno M; Takasaki M
    J Nucl Med; 2001 Oct; 42(10):1441-5. PubMed ID: 11585854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease.
    Venneri A; Shanks MF; Staff RT; Pestell SJ; Forbes KE; Gemmell HG; Murray AD
    Neuroreport; 2002 Jan; 13(1):83-7. PubMed ID: 11924899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period.
    López-Pousa S; Turon-Estrada A; Garre-Olmo J; Pericot-Nierga I; Lozano-Gallego M; Vilalta-Franch M; Hernández-Ferràndiz M; Morante-Muñoz V; Isern-Vila A; Gelada-Batlle E; Majó-Llopart J
    Dement Geriatr Cogn Disord; 2005; 19(4):189-95. PubMed ID: 15677866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study.
    Mossello E; Tonon E; Caleri V; Tilli S; Cantini C; Cavallini MC; Bencini F; Mecacci R; Marini M; Bardelli F; Sarcone E; Razzi E; Biagini CA; Masotti G
    Arch Gerontol Geriatr Suppl; 2004; (9):297-307. PubMed ID: 15207427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc-HMPAO and 99mTc-ECD brain uptake correlates of verbal memory in Alzheimer's disease.
    Nobili F; Koulibaly PM; Rodriguez G; Benoit M; Girtler N; Robert PH; Brugnolo A; Darcourt J
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):357-63. PubMed ID: 17220817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.